Global Pediatric Ventilators Market - 2022-2029

Global Pediatric Ventilators Market - 2022-2029

Market Overview

The global pediatric ventilators market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Neonatal/pediatric intensive care ventilators can help preterm and critically ill children who require total or partial assistance to maintain adequate ventilation.

Market Dynamics

The factors influencing the global pediatric market are the increasing demand for ventilators for pediatric and growing healthcare expenditure.

The increasing demand for ventilators for pediatric is expected to drive the market growth

Preterm and critically ill children who require total or partial assistance to maintain adequate ventilation can benefit from neonatal/pediatric intensive care ventilators. Some ventilators are designed specifically for neonatal/pediatric patients, while others, referred to as all-patient ventilators, can ventilate patients of all ages, from newborns to adults. Some of the six different ventilators from four different manufacturers are Bird, Dräger, Hamilton, and Siemens. Four of the units are all-patient models, while the fifth can ventilate patients from neonatal to pediatric, and the sixth is only for neonates. When a pediatric patient requires mechanical ventilation in the emergency department, the emergency clinician should be prepared to choose initial ventilator settings and respond to the dynamic physiologic needs of an intubated patient to ensure continued oxygenation, ventilation, and hemodynamic stability. In pediatric patients, pressure-targeted ventilation is generally recommended, with initial ventilator settings varying depending on age and the cause of respiratory failure. In the emergency department, pediatric patients may require ongoing critical care (including ventilator management). Children who are intubated and present to smaller community hospitals require active ventilator management while awaiting transfer to tertiary centers with pediatric critical care capabilities. It is critical that emergency clinicians effectively manage mechanical ventilation settings and related complications for pediatric patients.

Limitations associated with pediatric ventilators are expected to hamper the market growth

Respiratory failure is the most common reason for children being admitted to intensive care units, and the ventilator is the most common therapeutic tool used to treat these patients. Successful treatment requires a competently used ventilator and adequate knowledge of the respiratory system's anatomy, histology, and physiology in specific age groups of children (especially neonates and infants). Both non-invasive and invasive ventilation modes can be used for respiratory treatment in children. There are two types of invasive ventilation modes: traditional ones like pressure-controlled or volume-controlled ventilation and non-conventional ones like oscillatory ventilation. Mechanical ventilation carries a high risk of serious complications such as barotrauma (pressure injury), voltrauma (volume injury), and biotrauma (trauma to the body).

COVID-19 Impact Analysis

Pediatric ventilators are designed with children in mind. Children's breathing patterns differ from adult breathing patterns in that they have smaller tidal volumes (10mL/kg at birth) and a faster respiratory rate (40 bpm at birth, decreasing to 20 bpm at two years). As a result, pediatric ventilators treat respiratory and other breathing problems in children. Due to the emergence of coronavirus cases in infants and children, COVID-19 has a significant impact on the growth of pediatric ventilators. For instance, according to the Centers for Disease Control and Prevention (CDC), the Coronavirus pandemic caused >890,000 cases and >45,000 deaths worldwide as of April 2, 2020, with 239,279 cases 5,443 deaths in the United States. Thus, the market will grow over the forecast years due to the rapid growth of COVID-19 in children worldwide and the commendable role of pediatric ventilators in treating such children.

Segment Analysis

Portable/ Transportable Ventilators segment is expected to dominate the market growth

Portable ventilators are small devices that provide mechanical ventilation where piped gas and electricity are unavailable. These devices now have the sophistication of a traditional intensive care ventilator due to modern engineering. A portable ventilator, including oxygen and battery supplies, should be lightweight, robust, and low maintenance to function in demanding environments. It must economize on available gas and electricity. It should be low-cost, simple to use, and offer a variety of effective ventilation modes. The ventiPAC is a flow generator with a timer, and a portable gas-powered ventilator. A high-pressure gas supply drives a mechanical oscillator that controls the respiratory cycle. An adjustable flow restrictor limits the rate of gas delivery from the pressurized supply during inspiration. Most critical care transfers are done with pressurized cylinders, and utilizing their potential energy is relatively efficient. Under normal loading conditions, the operating controls on the front panel are calibrated. Despite increased airway resistance or reduced lung compliance, the ventilator will continue to provide reasonably accurate tidal volumes if 100 percent oxygen is delivered. In these conditions, however, if 'air mix' is selected, the backpressure imposed on the Venturi may reduce tidal volumes. As a result, end-tidal CO2 monitoring and, where possible, arterial blood gas sampling are required to monitor ventilation adequacy. Hence, with the advantages, portable ventilators provide, the market is expected to grow in the forecast period.

Geographical Analysis

North America region is expected to hold the largest market share in the global pediatric ventilators market

The growing demand for pediatric ventilators and increasing product launches in this region are expected to drive the market growth.

The number of ventilators needed to care for Covid-19 patients in the United States has been estimated to range from a few hundred thousand to a million. Of course, the number of ventilators required varies depending on the number, speed, and severity of infections, but even the availability of testing influences the number without adequate testing, patients who are traditionally treated with non-invasive positive-pressure ventilation (NIPPV) for conditions such as chronic obstructive pulmonary disease exacerbations may need to be presumptively intubated while awaiting Covid-19 testing resuscitation (using NIPPV is contraindicated for patients with Covid-19 because of aerosolization of the virus under positive pressure). The number of ventilators in the United States is currently estimated to be between 60,000 and 160,000, depending on whether or not those with only partial functionality are included. The national strategic reserve of ventilators is insufficient to cover the anticipated gap. Moreover, on 19th October 2020, in the United States, Getinge launched Servo-air, a high-performance ventilator for adult and pediatric patients. With Getinge's unique High Flow Therapy and Servo Compass options, Servo-air offers both invasive and non-invasive (NIV) ventilation modes. Servo-air is designed for mobility and uses hot-swappable battery technology to switch power sources without restarting the unit. Clinicians can adapt and personalize ventilation to the patient and situation using the included software modes.

Competitive Landscape

The global pediatric ventilators market is moderately competitive with mergers, acquisitions, and product launches. Some of the key players in the market are Philips Healthcare, ResMed, Medtronic, Becton, Dickinson and Company, Getinge, Dragerwerk AG, Smith's Group, Hamilton Medical, GE Healthcare, Fisher and Paykel Healthcare

Getinge

Overview: Getinge is a Swedish medical technology company founded in 1904. The company provides equipment and systems in the healthcare and life sciences industries.

Product Portfolio: The Servo-air ventilator is a mobile and easy-to-use ventilator for adult and paediatric patients now available in the United States. By being independent of wall-based gas units, having a hot-swappable battery, and traveling with patients as they are transferred intra-hospital, the new ventilator addresses multiple needs of COVID-19 treatment centers, including mobility and flexibility.

Key Development: On 19th October 2020, in the United States, Getinge launched Servo-air, a high-performance ventilator for adult and pediatric patients.